Your session is about to expire
← Back to Search
Exercise Training for Stroke Recovery
N/A
Recruiting
Led By John W Chow, PhD
Research Sponsored by Methodist Rehabilitation Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 1-2: baseline assessment (2-3 times); weeks 3-6: training (no assessment); week 7: post-training assessment (within 1 week after the end of training); week 10: follow-up assessment (4 weeks after the end of training)
Awards & highlights
Study Summary
This trial tests if exercise can improve lower-limb movement and strength in stroke survivors, and if the effects last after training ends.
Who is the study for?
This trial is for individuals who had a stroke between 6 months and 3 years ago, can walk at least 7 meters with or without help but slower than 1 meter per second, and can follow simple instructions. They should not have severe heart conditions, recent fractures, acute illnesses, or be in other strength training during the study.Check my eligibility
What is being tested?
The study tests a special exercise program designed to improve walking and muscle strength in the legs of people who've had strokes. Participants will do this training for four weeks and researchers believe it might lead to better gait and stronger leg muscles.See study design
What are the potential side effects?
While specific side effects are not listed for this type of physical therapy intervention, participants may experience general exercise-related discomfort such as muscle soreness or fatigue.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ weeks 1-2: baseline assessment (2-3 times); weeks 3-6: training (no assessment); week 7: post-training assessment (within 1 week after the end of training); week 10: follow-up assessment (4 weeks after the end of training)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 1-2: baseline assessment (2-3 times); weeks 3-6: training (no assessment); week 7: post-training assessment (within 1 week after the end of training); week 10: follow-up assessment (4 weeks after the end of training)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in Peak Knee Flexion Angle in the Swing Phase During Obstacle Crossing
Changes in Peak Knee Flexion Angle in the Swing Phase During Overground Gait
Changes in Speed During Obstacle Crossing
+5 moreSecondary outcome measures
Changes in 6-min Walk Distance
Changes in Force Steadiness
Changes in Lower Extremity Motor Function
+4 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Treatment ArmExperimental Treatment1 Intervention
Exercise training: Progressive resistance training of hip, knee, and ankle flexors.
Find a Location
Who is running the clinical trial?
Methodist Rehabilitation CenterLead Sponsor
6 Previous Clinical Trials
164 Total Patients Enrolled
John W Chow, PhDPrincipal InvestigatorMethodist Rehabiliation Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had a heart attack in the past.You walk slower than 1 meter per second.You can walk by yourself, with or without help, for about 23 feet.You are currently experiencing symptoms of heart disease or congestive heart failure.You had a stroke between 6 months and 3 years ago.Your blood pressure is not well controlled and is higher than 150/90 mm Hg.You have broken a bone in your leg within the last 6 months.You have a severe illness that has just started or is very advanced.You have previously taken part in a stroke physical therapy program without experiencing severe symptoms like shortness of breath, headache, or extreme tiredness.You are currently doing strength training or supervised physical therapy.You have issues with your leg joints or muscles.You have difficulty moving your hips and knees in a certain way, as measured by a specific assessment.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this trial accessible at the present time?
"Based on clinicaltrials.gov, this trial is currently open for enrolment. It was first created on June 3rd 2019 and the details have been modified as recently as May 8th 2023."
Answered by AI
What is the maximum capacity for participants in this medical research?
"Indeed, the clinicaltrials.gov website verifies that this medical trial is still enrolling patients. The investigation was initially posted on June 3rd 2019 with a final update coming through May 8th 2023 and requires 10 participants from one site to complete its goals."
Answered by AI
What goals is this research endeavor attempting to accomplish?
"The primary aim of this trial, which will be conducted over the course of two weeks in baseline assessment and seven weeks post-training, is to evaluate changes in speed during overground gait. Secondary objectives include assessing alterations in force steadiness, muscle activation profiles during overground walking, and lower extremity motor function as measured by Fugl-Meyer Assessment scores before and after training with a follow-up 4 weeks later."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger